I am currently using a B16F10 (murine melanoma) cell line for my anti-tyrosinase experiments. However, there are times where I noticed that the same treatments (e.g., my compounds at the concentration of 250ug/ml) would produce vastly different results in terms of cellular tyrosinase activities and melanin productions.

Besides, there are also times where the same treatments would reduce the tyrosinase activity with no effect on melanin production on cells (e.g. in p5), and reduce the melanin production with no effect on tyrosinase activity on cells (p.g. in p6).

I've done multiple "exclusion" works such as amending the FBS (brands, lots, heat-inactivation, concentrations etc.), with and without antibiotics (PenStrep, Gentamicin, etc.), additives on medium (HEPES, L-glutamine), yet the performances of the cells still fluctuate at times.

Is there any special attentions or conditions that I need to adhere to? I would appreciate if colleagues who are currently working or have worked with B16F10 cells (or B16, B16F1, etc.) would kindly provide their insights or opinions of their works with the cells.

Similar questions and discussions